Mu Opioid Receptor Modulation of Dopamine Neurons in the Periaqueductal Gray/Dorsal Raphe: A Role in Regulation of Pain

Akaike A, Shibata T, Satoh M, Takagi H (1978). Analgesia induced by microinjection of morphine into, and electrical stimulation of, the nucleus reticularis paragigantocellularis of rat medulla oblongata. Neuropharmacology 17: 775–778.

Bath BD, Michael DJ, Trafton BJ, Joseph JD, Runnels PL, Wightman RM (2000). Subsecond adsorption and desorption of dopamine at carbon-fiber microelectrodes. Anal Chem 72: 5994–6002.

Beiske AG, Loge JH, Ronningen A, Svensson E (2009). Pain in Parkinson's disease: prevalence and characteristics. Pain 141: 173–177.

Bergevin A, Girardot D, Bourque MJ, Trudeau LE (2002). Presynaptic mu-opioid receptors regulate a late step of the secretory process in rat ventral tegmental area GABAergic neurons. Neuropharmacology 42: 1065–1078.

Budai D, Fields HL (1998). Endogenous opioid peptides acting at mu-opioid receptors in the dorsal horn contribute to midbrain modulation of spinal nociceptive neurons. J Neurophysiol 79: 677–687.

Crown ED, King TE, Meagher MW, Grau JW (2000). Shock-induced hyperalgesia: III. Role of the bed nucleus of the stria terminalis and amygdaloid nuclei. Behav Neurosci 114: 561–573.

Deyama S, Nakagawa T, Kaneko S, Uehara T, Minami M (2007). Involvement of the bed nucleus of the stria terminalis in the negative affective component of visceral and somatic pain in rats. Behav Brain Res 176: 367–371.

Dougalis AG, Matthews GA, Bishop MW, Brischoux F, Kobayashi K, Ungless MA (2012). Functional properties of dopamine neurons and co-expression of vasoactive intestinal polypeptide in the dorsal raphe nucleus and ventro-lateral periaqueductal grey. Eur J Neurosci 36: 3322–3332.

Espejo EF, Stinus L, Cador M, Mir D (1994). Effects of morphine and naloxone on behaviour in the hot plate test: an ethopharmacological study in the rat. Psychopharmacology 113: 500–510.

Finn DP, Jhaveri MD, Beckett SR, Roe CH, Kendall DA, Marsden CA et al (2003). Effects of direct periaqueductal grey administration of a cannabinoid receptor agonist on nociceptive and aversive responses in rats. Neuropharmacology 45: 594–604.

Flores JA, El Banoua F, Galan-Rodriguez B, Fernandez-Espejo E (2004). Opiate anti-nociception is attenuated following lesion of large dopamine neurons of the periaqueductal grey: critical role for D1 (not D2) dopamine receptors. Pain 110: 205–214.

Franklin KJ, Abbott F (1989) Techniques for assessing the effects of drugs on nociceptive responses. In: Boulton A et al (ed). Psychopharmacology, Vol. 13, Humana Press: Clifton, NJ, pp 145–216.

Hahm ET, Kim Y, Lee JJ, Cho YW (2011). GABAergic synaptic response and its opioidergic modulation in periaqueductal gray neurons of rats with neuropathic pain. BMC Neurosci 12: 41.

Heimer R, Zhan W, Grau LE (2015). Prevalence and experience of chronic pain in suburban drug injectors. Drug Alcohol Depend 151: 92–100.

Hnasko TS, Chuhma N, Zhang H, Goh GY, Sulzer D, Palmiter RD et al (2010). Vesicular glutamate transport promotes dopamine storage and glutamate corelease in vivo. Neuron 65: 643–656.

Hong J, Novick D, Montgomery W, Aguado J, Duenas H, Peng X et al (2015). Should unexplained painful physical symptoms be considered within the spectrum of depressive symptoms? Clin Pract Epidemiol Ment Health 11: 130–139.

Jarcho JM, Mayer EA, Jiang ZK, Feier NA, London ED (2012). Pain, affective symptoms, and cognitive deficits in patients with cerebral dopamine dysfunction. Pain 153: 744–754.

Johnson SW, North RA (1992). Opioids excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci 12: 483–488.

Kash TL, Nobis WP, Matthews RT, Winder DG (2008). Dopamine enhances fast excitatory synaptic transmission in the extended amygdala by a CRF-R1-dependent process. J Neurosci 28: 13856–13865.

Kim EJ, Horovitz O, Pellman BA, Tan LM, Li Q, Richter-Levin G et al (2013a). Dorsal periaqueductal gray-amygdala pathway conveys both innate and learned fear responses in rats. Proc Natl Acad Sci USA 110: 14795–14800.

Kim SY, Adhikari A, Lee SY, Marshel JH, Kim CK, Mallory CS et al (2013b). Diverging neural pathways assemble a behavioural state from separable features in anxiety. Nature 496: 219–223.

Lecca S, Melis M, Luchicchi A, Muntoni AL, Pistis M (2012). Inhibitory inputs from rostromedial tegmental neurons regulate spontaneous activity of midbrain dopamine cells and their responses to drugs of abuse. Neuropsychopharmacology 37: 1164–1176.

Li C, McCall NM, Lopez AJ, Kash TL (2013). Alcohol effects on synaptic transmission in periaqueductal gray dopamine neurons. Alcohol 47: 279–287.

Lupica CR (1995). Delta and mu enkephalins inhibit spontaneous GABA-mediated IPSCs via a cyclic AMP-independent mechanism in the rat hippocampus. J Neurosci 15: 737–749.

Margolis EB, Hjelmstad GO, Fujita W, Fields HL (2014). Direct bidirectional mu-opioid control of midbrain dopamine neurons. J Neurosci 34: 14707–14716.

Mayer DJ, Wolfle TL, Akil H, Carder B, Liebeskind JC (1971). Analgesia from electrical stimulation in the brainstem of the rat. Science 174: 1351–1354.

Minami M, Ide S (2015). How does pain induce negative emotion? Role of the bed nucleus of the stria terminalis in pain-induced place aversion. Curr Mol Med 15: 184–190.

Morano TJ, Bailey NJ, Cahill CM, Dumont EC (2008). Nuclei-and condition-specific responses to pain in the bed nucleus of the stria terminalis. Prog Neuropsychopharmacol Biol Psychiatry 32: 643–650.

Rizvi TA, Ennis M, Behbehani MM, Shipley MT (1991). Connections between the central nucleus of the amygdala and the midbrain periaqueductal gray: topography and reciprocity. J Comp Neurol 303: 121–131.

Silberman Y, Winder DG (2013). Corticotropin releasing factor and catecholamines enhance glutamatergic neurotransmission in the lateral subdivision of the central amygdala. Neuropharmacology 70: 316–323.

Stuber GD, Hnasko TS, Britt JP, Edwards RH, Bonci A (2010). Dopaminergic terminals in the nucleus accumbens but not the dorsal striatum corelease glutamate. J Neurosci 30: 8229–8233.

Tan KR, Brown M, Labouebe G, Yvon C, Creton C, Fritschy JM et al (2010). Neural bases for addictive properties of benzodiazepines. Nature 463: 769–774.

Tecuapetla F, Patel JC, Xenias H, English D, Tadros I, Shah F et al (2010). Glutamatergic signaling by mesolimbic dopamine neurons in the nucleus accumbens. J Neurosci 30: 7105–7110.

Tritsch NX, Ding JB, Sabatini BL (2012). Dopaminergic neurons inhibit striatal output through non-canonical release of GABA. Nature 490: 262–266.

Tykocki T, Kornakiewicz A, Mandat T, Nauman P (2013). Pain perception in patients with Parkinson's disease. J Clin Neurosci 20: 663–666.

Vaughan CW, Ingram SL, Connor MA, Christie MJ (1997). How opioids inhibit GABA-mediated neurotransmission. Nature 390: 611–614.

Vianna DM, Brandao ML (2003). Anatomical connections of the periaqueductal gray: specific neural substrates for different kinds of fear. Braz J Med Biol Res 36: 557–566.

Weaver M, Schnoll S (2002). Abuse liability in opioid therapy for pain treatment in patients with an addiction history. Clin J Pain 18: S61–S69.

Wood PB (2008). Role of central dopamine in pain and analgesia. Expert Rev Neurother 8: 781–797.

Xie G, Hipolito L, Zuo W, Polache A, Granero L, Krnjevic K et al (2012). Salsolinol stimulates dopamine neurons in slices of posterior ventral tegmental area indirectly by activating mu-opioid receptors. J Pharmacol Exp Ther 341: 43–50.